R&D Strategy
At Ferrer we focus on identifying projects that have a differential value
We have therefore adopted a dynamic R&D strategy that aims to improve our understanding of diseases, thus propelling the development of potentially transformative new therapies in our two core therapeutic areas.
This development is guided by patient itineraries that reflect patients’ real needs, which enables us to make intelligent, well-integrated decisions to quickly adapt and respond to new challenges and opportunities.
When we research, create, innovate, and develop
We always keep patients and their needs in mind
We work on behalf of patients to bring them life-changing treatments, products that revolutionise drug efficacy and improve their quality of life.
Our product pipeline
Our innovative approach has resulted in multiple product candidates in the pipeline that have the potential to offer patients a better quality of life
Our researchers are constantly evaluating opportunities to develop and provide important, differentiated solutions.
Our technologies
The Staccato® system
The Staccato system uses a rapid heating system capable of reaching very high temperatures in as little as 100 milliseconds to vaporise the unformulated active pharmaceutical ingredient, which is deposited in a thin layer on a stainless steel substrate.
When the patient inhales through the Staccato system, the surface of the stainless steel substrate heats up instantly, creating aerosolised drug particles.
The patient inhales these particles, which are optimally sized to reach the deepest and most vascularised areas of the lung.
This brings about rapid and complete absorption into the bloodstream.
Our clinical trials
Ferrer’s researchers strive to treat diseases and their associated symptoms
Clinical studies involving healthy volunteers and patients play a key role in the development of new medicines.
Patients are enrolled in clinical trials that comply with the principles of the Declaration of Helsinki and its amendments, as well as the laws and regulations of the countries where the volunteers are enrolled.
Check out our clinical trials on our website.
Innovation
We offer full commercial and development capabilities through any one of our innovation portals:
ferrer4FUTURE
Our purpose is to develop digital and technological solutions aligned with Ferrer’s therapeutic approach and adding value throughout the value chain of patient care, addressing real unmet clinical needs.
We develop these solutions by applying concepts of open innovation and co-development through our programme ferrer4FUTURE (F4F) programme, the bridge between Ferrer and digital health start-ups.
Ferrer Open
Ferrer Open promotes and facilitates contact with the most innovative players in the ecosystem in order to attract and, in some cases, create value-added treatment solutions that fall within Ferrer’s areas of specialisation: pulmonary vascular and interstitial lung diseases and neurological disorders.